medigraphic.com
ISSN 0016-3813 (Print)

2013, Number 5

<< Back Next >>

Gac Med Mex 2013; 149 (5)

Mortality trends and years of potential life lost from prostate cancer in the 32 states and 7 sociecononomic regions of Mexico, 2000-2010

Sánchez-Barriga JJ

Language: Spanish
References: 24
Page: 576-585
PDF size: 101.33 Kb.


ABSTRACT

Objective: To determine trends of mortality from prostate cancer (PC) and years of potential life lost (YPLL) by federative entity and by socioeconomic region in the period 2000-2010. Methods: Records of mortality associated with PC 2000-2010 were obtained from the National Information System of the Secretariat of Health. This information is generated by the National Institute of Statistics and Geography through death certificates issued throughout the country. International Classification of Diseases, 10th revision, codes corresponding to the basic cause of death from PC were identified. Rates of mortality nationwide, by state, and by socioeconomic region were calculated. Rates of YPLL were calculated by federative entity and by socioeconomic region. The seven socioeconomic regions were elaborated by the National Institute of Statistics and Geography and include the 31 states and Mexico City according to indicators that are related to well-being such as education, occupation, health, housing, and employment. Results: Raw mortality rates per 100,000 inhabitants who died from PC increased from 7.8 to 9.8 between 2000-2010. The states and socioeconomic regions with the higher rates of mortality from PC were Sinaloa, Sonora, Baja California Sur, Nayarit, Colima and regions 6 and 3. The state and socioeconomic regions with higher rate of APVP from PC were Aguascalientes, Nuevo León, Campeche, Baja California Sur, Durango and regions 6, 5, 3, 1 and 2. Conclusions: Raw mortality rates per 100,000 inhabitants who died from PC increased from 7.8 to 9.8 between 2000-2010. The states and socioeconomic region with the higher mortality rates were Sinaloa, Sonora, Baja California Sur, Nayarit, Colima and regions 6 and 3. Mexico.


REFERENCES

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer-Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Disponible en: http://globocan.iarc.fr.

  2. Brawley OW. Prostate cancer epidemiology in the United States. World J Urol. 2012;30:195-200.

  3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11-30.

  4. Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079-92.

  5. Malvezzi M, Bosetti C, Chatenoud L, et al. Trends in cancer mortality in Mexico, 1970-1999. Ann Oncol. 2004;15:1712-8.

  6. Secretaría de Salud. Sistema Nacional de Información en Salud. Principales causas de mortalidad en hombres. Disponible en: http://sinais.salud.gob.mx/mortalidad.

  7. Secretaría de Salud. Sistema Nacional de Información en Salud. Mortalidad. Disponible en: http://sinais.salud.gob.mx/mortalidad.

  8. World Health Organization. International Statistical Classification of Diseases and Problems related to health. Tenth review CIE10. Geneva: World Health Organization; 1995.

  9. Inskip H, Beral V, Fraser P, Haskey J. Methods for age-adjustment of rates. Stat Med. 1983;2:455-66.

  10. Ahmad OB, Boschi-Pinto C, López AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. In: Global program on evidence for health policy discussion paper. Series 31. Geneva: WHO; 1999. p. 1-12.

  11. Consejo Nacional de Población. Proyecciones de población en México 2000-2030.

  12. Romeder JM, McWhinnie JR. Potential years of life lost between ages 1 and 70: an indicator of premature mortality for health planning. Int J Epidemiol. 1977;6:143-51.

  13. Organización Panamericana de la Salud. Técnicas para la medición del impacto de la mortalidad: años potenciales de vida perdidos. Bol Epidemiol. 2003;24(2):1-4.

  14. Consejo Nacional de Población. República Mexicana: Indicadores demográficos, 2010-2050. http://www.conapo.gob.mx/es/CONAPO/Proyecciones_de_la_Poblacion_2010-2050.

  15. Instituto Nacional de Estadística y Geografía. Regiones Socioeconómicas de México. Disponible en: http://sc.inegi.org.mx/niveles/datosnbi/reg_soc_mexico.pdf.

  16. Tovar-Guzmán V, Hernández-Girón C, López-Ríos O, Lazcano-Ponce EC. Prostate cancer mortality trends in Mexico, 1980-1995. Prostate. 1999;39:23-7.

  17. Saunders LR, Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene. 2007;26:5489-504.

  18. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública (MX); 2012.

  19. Rodríguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev. 2001;10:345-53.

  20. Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci. 2006;11:1388-413.

  21. Rapiti E, Fioretta G, Schaffar R, et al. Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis. Cancer. 2009;115:5556-65.

  22. Hsing AW, Sakoda LC, Chua S Jr. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr. 2007;86(Suppl):843-57.

  23. Gómez-Guerra LS, Martínez-Fierro ML, Alcántara-Aragón V, et al. Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases. BMC Cancer. 2009;9:91.

  24. Liang Y, Messer JC, Louden C, Jiménez-Ríos MA, Thompson IM, Camarena-Reynoso HR. Prostate cancer risk prediction in a urology clinic in Mexico. Urol Oncol. 2012.




2020     |     www.medigraphic.com